文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症患者的RNA测序为快速诊断病原体及耐药性提供检测靶点

RNA Sequencing of Sepsis Patients Informs Tests to Quickly Diagnose Pathogens and Resistance.
PubMed 文献 · Shock · 2026-02-13
一句话结论脓毒症患者RNA测序可识别病原体RNA并设计PCR引物,在部分队列中检出所有血培养阳性的铜绿假单胞菌和金黄色葡萄球菌病例,有望比血培养更快诊断。

该队列研究纳入46例收入ICU的脓毒症患者,采集87个时间点样本,获得86亿条RNA测序读数,用于识别病原体RNA并设计新型PCR检测。PCR靶点发现聚焦于血培养阳性样本(共40份),涉及大肠埃希菌(5份)、金黄色葡萄球菌(6份)和铜绿假单胞菌(3份)及耐药基因。从测序读数中定义40个靶点并用定量PCR检测;在46例中9例有可用样本的队列里,部分所提出的PCR检出了所有血培养阳性的铜绿假单胞菌和金黄色葡萄球菌病例,该队列中大肠埃希菌无血培养阳性。作者认为将这些引物转化到临床微生物学仪器上可实现比血培养更快的诊断。

要点

  • 46例ICU脓毒症患者、87个时间点样本获86亿条RNA测序读数,用于识别病原体RNA。
  • PCR靶点发现基于40份血培养阳性样本:大肠埃希菌5份、金黄色葡萄球菌6份、铜绿假单胞菌3份,并识别耐药基因。
  • 从RNA测序读数定义40个靶点并以定量PCR检测。
  • 在9例有可用样本的患者中,部分所提出的PCR检出了所有血培养阳性的铜绿假单胞菌和金黄色葡萄球菌病例;该队列中大肠埃希菌无血培养阳性。
  • 作者认为将这些引物转化到临床微生物学仪器上,可实现比血培养更快的诊断。

适用人群与场景

  • 收入重症监护病房的脓毒症患者,纳入研究前获取知情同意。

研究设计与关键结果

  • 研究类型为队列研究;纳入46例脓毒症患者,采集87个时间点样本,获得86亿条RNA测序读数用于识别病原体RNA。
  • PCR靶点发现聚焦于血培养阳性样本(共40份),涉及大肠埃希菌(5份样本)、金黄色葡萄球菌(6份样本)和铜绿假单胞菌(3份样本),并识别耐药基因。
  • 从RNA测序读数中定义40个靶点并用定量PCR检测。
  • 在46例中9例有可用样本的患者队列中,部分所提出的PCR检出了所有血培养阳性的铜绿假单胞菌和金黄色葡萄球菌病例;该队列中大肠埃希菌无血培养阳性。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,将这些PCR引物转化到临床微生物学仪器上,将允许比血培养更快地诊断脓毒症病原体。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Diagnosis of infection in patients with sepsis takes days via culture, and appropriate treatment of pathogens is delayed awaiting results. We hypothesize that we can use RNA sequencing from patients with sepsis to identify novel targets for faster nucleic acid-based tests.

METHODS: Cohort study of sepsis patients admitted to the intensive care unit with RNA sequencing was done after obtaining the consent. RNA sequencing data that did not map to the human genome were then aligned to resistance genes and pathogen genomes and used to design novel polymerase chain reaction (PCR) tests. These tests were correlated with blood culture diagnosis and clinical outcomes.

RESULTS: Forty-six patients were enrolled, and samples from 87 time points were collected. These samples resulted in 8.6 billion RNA sequencing reads to identify pathogen RNA. PCR target discovery focused on positive blood cultures (n = 40 total) due to Escherichia coli (five samples), Staphylococcus aureus (six samples), and Pseudomonas aeruginosa (three samples) as well as identification of resistance genes. From RNA sequencing reads, 40 targets were defined and tested by quantitative PCR. In a cohort of patients (9 of 46) with available samples, some of the proposed PCRs identified all cases of positive blood cultures ( P. aeruginosa and S. aureus ); E. coli had no positive blood cultures in this cohort.

CONCLUSIONS: RNA sequencing from patients with sepsis can identify RNA from pathogens causing the infection. This is used to design PCR primers that identify patients with positive blood cultures. Translation of these primers to clinical microbiology machines will allow the diagnosis faster than blood culture.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Monaghan SF, Shin J, Armstead BE, et al. RNA Sequencing of Sepsis Patients Informs Tests to Quickly Diagnose Pathogens and Resistance. Shock. 2026. PMID: 41697057. doi:10.1097/SHK.0000000000002756

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。